StockMarketWire.com - Sensyne Health said it had launched a patient app-to-clinician software system for the management of gestational diabetes mellitus.

The software, called GDm-Health, replaced the traditional paper-based method of management, the company said.

It comprised a smartphone application that connected to a wireless blood glucose monitor.

Its development was completed following a two-year clinical evaluation in the NHS by over 1,000 women, the company said.


At 9:10am: [LON:SENS] Sensyne Health Plc Ord 10p share price was +2.5p at 195p



Story provided by StockMarketWire.com